SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--InterVenn Biosciences today announced that it will be participating via webcast in the Morgan Stanley 19th Annual Global Healthcare Conference.
Aldo Carrascoso, CEO is scheduled to participate in a fireside chat on Friday, September 10th, 2021 at 11:45 a.m. ET.
Please follow the link (https://intervenn.com/investors/) to the “Investors” page on the InterVenn website and a live webcast of the event.
About InterVenn Biosciences
InterVenn Biosciences utilizes a proprietary glycoproteomics biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. For more information about InterVenn Biosciences, please visit the company’s website.
